Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Neurology|January 26, 2007
Relevance of 10-min delayed recall in dementia screeningJ de Rotrou, L Battal-Merlet, E Wenisch, et al.
Dementia and Geriatric Cognitive Disorders|May 16, 2012
DAD-6: A 6-ltem version of the Disability Assessment for Dementia scale which may differentiate Alzheimer's disease and mild cognitive impairment from controlsJ de Rotrou, Y-H Wu, L Hugonot-Diener, et al.
European Neurology|March 27, 1998
Detection of cerebral aging, an absolute need: predictive value of cognitive statusF Forette, M L Seux, L Thijs, et al.
European Journal of Neurology|July 25, 2000
The apolipoprotein E epsilon4 allele and the response to tacrine therapy in Alzheimer's diseaseA S Rigaud, L Traykov, L Caputo, et al.
European Journal of Neurology|June 11, 1999
Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular diseaseL Traykov, A S Rigaud, L Caputo, et al.
Brain : a Journal of Neurology|January 29, 2000
Preservation of midbrain catecholaminergic neurons in very old human subjectsN Kubis, B A Faucheux, G Ransmayr, et al.
European Journal of Neurology|November 29, 2013
A double-blind, placebo-controlled, enriched population study of tacrine in patients with Alzheimer's diseaseF Forette, T Hoover, S Gracon, et al.
The Journal of Nutrition, Health & Aging|August 3, 2011
IAGG workshop: health promotion program on prevention of late onset dementiaS Andrieu, I Aboderin, J P Baeyens, et al.
Dementia and Geriatric Cognitive Disorders|September 29, 2011
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjectsJ Norberg, C Graff, O Almkvist, et al.
Neuroepidemiology|June 3, 2008
Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA StudyP J Visser, F R J Verhey, M Boada, et al.
Pageof 8